MarketCapTrends
ASMB

Assembly Biosciences Inc. (ASMB)

NASDAQ · Healthcare

Assembly Biosciences Inc. annual/quarterly shareholder equity history from 2016 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.

  • Assembly Biosciences Inc. shareholder equity for the quarter ending December 31, 2025 were 206.8M, a 519.78% increase year-over-year.
  • Assembly Biosciences Inc. shareholder equity for 2025 were 206.8M, a 519.78% increase from 2024.
  • Assembly Biosciences Inc. shareholder equity for 2024 were 33.4M, a 18.83% decrease from 2023.
  • Assembly Biosciences Inc. shareholder equity for 2023 were 41.1M, a 50.28% decrease from 2022.
  • Assembly Biosciences Inc. shareholder equity for 2022 were 82.7M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Assembly Biosciences Inc. Annual Shareholder Equity (Millions of US $)
2025$207
2024$33
2023$41
2022$83
2021$169
2020$241
2019$273
2018$211
2017$113
2016$80
Assembly Biosciences Inc. Quarterly Shareholder Equity (Millions of US $)
2025-12-31$207
2024-12-31$33
2023-12-31$41
2022-12-31$83
2021-12-31$169
2020-12-31$241
2019-12-31$273
2018-12-31$211
2017-12-31$113
2016-12-31$80

Assembly Biosciences Inc. Shareholder Equity — FAQ

Assembly Biosciences Inc. (ASMB) shareholder equity over the last 10 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see ASMB's shareholder equity history?

The chart and table above show Assembly Biosciences Inc.'s shareholder equity by year and by quarter, including the growth rate.